Covalon Technologies Ltd. (CVALF)
OTC
Closed
Oct 5, 2026
Day's Range
2.8152 wk Range
1.16Overview - CVALF - Covalon Technologies Ltd.
Key Statistics
Valuation
Enterprise Value
39.95M
P/E (Trailing)
‪24.54‬
P/E (Forward)
‪19.21‬
Price / Sales (TTM)
‪2.17‬
Price / Book
‪3.36‬
EV / EBITDA
‪14.03‬
Profitability
Gross Margin
‪67.18%‬
Profit Margin
‪12.77%‬
Operating Margin
‪27.16%‬
Return on Assets
‪6.86%‬
Return on Equity
‪14.33%‬
Ownership
Shares Outstanding
27.61M
Float
14.94M
Held by Insiders
‪47.16%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.13‬
50-Day Avg
‪2.11‬
200-Day Avg
‪1.56‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CVALF - Covalon Technologies Ltd.
Peers - CVALF - Covalon Technologies Ltd.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on OTC.
Profile Summary - CVALF - Covalon Technologies Ltd.
About
Covalon Technologies Ltd. is a medical technology company that specializes in developing, licensing, and commercializing innovative healthcare products. The primary focus of the company is on advanced wound care and infection prevention solutions, addressing critical needs in the healthcare industry. Covalon's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
